The power of preclinical imaging in CAR-T cell research

Dr. Mark Sellmyer, a leader in molecular imaging at the University of Pennsylvania, is pioneering the use of micro-PET to advance CAR-T cell research. Leveraging innovative tools such as PET reporter genes and imaging, his lab aims to unravel the dynamics of CAR-T cells in vivo, optimizing their safety and therapeutic efficacy. With this research, Dr. Sellmyer is not only driving scientific discovery but also paving the way for precise and impactful cancer treatments.